IRM (NYSE: IRM) insider Mark Kidd files to sell 6,000 shares

Rhea-AI Filing Summary

Mark Kidd filed to sell common stock of IRM through Fidelity Brokerage Services LLC. The filing lists a planned sale of 6,000 shares with an aggregate value of $736,200.00, to be sold on the NYSE on or after August 7, 2026.

The disclosure also lists prior open‑market sales of 6,000 shares each on May 8, 2026 for $767,460.00, June 1, 2026 for $760,200.00, and July 1, 2026 for $753,720.00. Earlier entries show multiple restricted stock vesting events classified as compensation.

Key Figures

Planned shares to be sold: 6,000 shares Planned aggregate sale value: $736,200.00 Sale on May 8, 2026: 6,000 shares; $767,460.00 +2 more

5 metrics

Planned shares to be sold 6,000 shares Common stock sale planned on or after August 7, 2026

Planned aggregate sale value $736,200.00 Aggregate value for 6,000 IRM common shares through Fidelity on NYSE

Sale on May 8, 2026 6,000 shares; $767,460.00 IRM common stock sold by Mark Kidd during past three months

Sale on June 1, 2026 6,000 shares; $760,200.00 IRM common stock sold by Mark Kidd during past three months

Sale on July 1, 2026 6,000 shares; $753,720.00 IRM common stock sold by Mark Kidd during past three months

Key Terms

Form 144, Restricted Stock Vesting, Compensation, Rule 144

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 02/15/2019 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"02/24/2021 | Restricted Stock Vesting | Issuer | | | 551 | 02/24/2021 | Compensation"

Rule 144 regulatory

"144: Securities Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 01:40 PM Accepted by SEC EDGAR 08/07/2026 - 01:40 PM Learn about SEC filing dates

FAQ

What stock sale is being planned in this Form 144 related to IRM?

The filing shows a planned sale of 6,000 shares of IRM common stock with an aggregate value of $736,200.00, to be sold through Fidelity Brokerage Services LLC on the NYSE on or after August 7, 2026.

Who is the selling security holder in this IRM Form 144 filing?

The selling security holder is Mark Kidd, with an address at 85 New Hampshire Avenue, Suite 150, Portsmouth, NH 03801. The filing relates to his planned and recent sales of IRM common stock under Rule 144.

What IRM stock sales has Mark Kidd made in the past three months?

The filing lists three sales of 6,000 IRM shares each: on May 8, 2026 for $767,460.00, June 1, 2026 for $760,200.00, and July 1, 2026 for $753,720.00, all in IRM common stock.

On which exchange will the planned IRM stock sale occur?

The planned sale of 6,000 IRM common shares is indicated for trading on the NYSE. The aggregate value for this sale is listed as $736,200.00, with Fidelity Brokerage Services LLC acting as the brokerage.

What is the significance of the restricted stock vesting entries for IRM?

The filing records several restricted stock vesting events in 2019–2021, all classified as Compensation from the issuer. These entries document when IRM common stock vested to the reporting person under prior equity awards.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6000	736200.00	297702812	08/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2019	Restricted Stock Vesting	Issuer			968	02/15/2019	Compensation
Common	02/16/2019	Restricted Stock Vesting	Issuer			1285	02/16/2019	Compensation
Common	02/18/2019	Restricted Stock Vesting	Issuer			770	02/18/2019	Compensation
Common	03/09/2019	Restricted Stock Vesting	Issuer			488	03/09/2019	Compensation
Common	02/16/2020	Restricted Stock Vesting	Issuer			461	02/16/2020	Compensation
Common	02/20/2020	Restricted Stock Vesting	Issuer			1477	02/20/2020	Compensation
Common	02/24/2021	Restricted Stock Vesting	Issuer			551	02/24/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Kidd 85 New Hampshire Avenue Suite 150 Portsmouth NH 03801	Common	05/08/2026	6000	767460.00
Mark Kidd 85 New Hampshire Avenue Suite 150 Portsmouth NH 03801	Common	06/01/2026	6000	760200.00
Mark Kidd 85 New Hampshire Avenue Suite 150 Portsmouth NH 03801	Common	07/01/2026	6000	753720.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)